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Abstract
Protein aggregation and amyloid formation are associated with multiple human diseases, but are also a problem in protein 
production. Understanding how aggregation can be modulated is therefore of importance in both medical and industrial 
contexts. We have used bovine insulin as a model protein to explore how amyloid formation is affected by buffer pH and by 
the addition of short-chain alcohols. We find that bovine insulin forms amyloid fibrils, albeit with different rates and resulting 
fibril morphologies, across a wide pH range (2–7). At pH 4.0, bovine insulin displayed relatively low aggregation propen-
sity in combination with high solubility; this condition was therefore chosen as basis for further exploration of how bovine 
insulin’s native state can be stabilized in the presence of short-chain alcohols that are relevant because of their common use 
as eluents in industrial-scale chromatography purification. We found that ethanol and isopropanol are efficient modulators 
of bovine insulin aggregation, providing a three to four times retardation of the aggregation kinetics at 30–35% (vol/vol) 
concentration; we attribute this to the formation of oligomers, which we detected by AFM. We discuss this effect in terms 
of reduced solvent polarity and show, by circular dichroism recordings, that a concomitant change in α-helical packing of 
the insulin monomer occurs in ethanol. Our results extend current knowledge of how insulin aggregates, and may, although 
bovine insulin serves as a simplistic model, provide insights into how buffers and additives can be fine-tuned in industrial 
production of proteins in general and pharmaceutical insulin in particular.
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Introduction
Protein aggregation and formation of amyloid fibrils are 
underlying causes of many common and devastating disor-
ders (Chiti and Dobson 2006), but can also be a significant 
problem in the biotechnological industry. Protein aggrega-
tion can cause trouble in all phases of protein production as 
well as during storage and administration of protein biop-
harmaceuticals (Wang 2005; Frokjaer and Otzen 2005). 
Amyloid fibrils are highly stable protein homopolymers, 
which can be formed by most polypeptide chains (Dobson 
2001; Fändrich and Dobson 2002). Despite the large struc-
ture and size variations among amyloid-forming proteins, 
the fibrils themselves share important structural and mor-
phological traits; they have diameters around 10 nm, can 
extend several microns in length, and are typically twisted 
and unbranched (Sunde et al. 1997). They also share a com-
mon cross-β fold and are stabilized by extensive intermolec-
ular hydrogen bonding involving the polypeptide backbone 
(Sunde et al. 1997). Proteins differ, however, substantially 
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in the propensity and conditions in which they form fibrils. 
Understanding these characteristics and the effect of extrin-
sic modulators is important not only in cases where amyloid-
forming proteins give rise to disease, but also for the opti-
mization of industrial procedures to avoid or reduce adverse 
amyloid formation.
Bovine insulin is a 5.8 kDa peptide hormone with 51 
amino acid residues, distributed over two polypeptide chains 
(A and B) that are interconnected by disulphide bridges (Hua 
et al. 2002). It is produced in β-cells of the pancreatic islets 
and secreted in response to elevated glucose levels in the 
blood. In this capacity, the human counterpart has become 
the most commonly used drug for treatment of diabetes mel-
litus, and hence one of the world’s major biopharmaceu-
tical products (Walsh 2005). Natively folded insulin, both 
bovine and human, is predominately α-helical; its three-
dimensional structure was solved by X-ray crystallography 
already in 1969 (Adams et al. (1969)). Insulin functionality 
is dependent on its quaternary structure; the folded protein 
can assemble into different oligomers, with the monomer 
as the biologically active form (Hefford et al. 1986). In 
aqueous solution, natively folded insulin monomers exist in 
equilibrium with dimers, tetramers, and hexamers (Brange 
and Langkjoer 1993; Nettleton et al. 2000; Pekar and Frank 
1972). The assembly state is dependent on solution con-
ditions; the monomer is for example favoured at low pH, 
particularly in acetic acid (Attri et al. 2010), whereas dimers 
are favoured in hydrochloric acid, and hexamers are strongly 
stabilized by higher pH and presence of zinc ions (Brange 
and Langkjoer 1993; Pekar and Frank 1972). Insulin is, in 
addition, an amyloidogenic protein that readily converts into 
fibrils in vitro (Waugh 1946); Burke et al. 1972). High con-
centration, or conditions that destabilize the native state, e.g. 
low pH and elevated temperatures promote such reactions 
(Waugh 1946; Brange et al. 1997). Most evidence suggests 
that insulin fibrillation proceeds from the monomeric state, 
and that dimer, tetramer, and hexamer formation thereby act 
as protective in regard to fibril formation (Brange et al. 1997; 
Ziaunys et al. 2018; Brunetti and Waldhäusl 1987; Nielsen 
et al. 2001; Waugh et al. 1953). Insulin fibrillation can cause 
significant complications in diabetes therapy, either directly 
due to injection site amyloidosis (Nilsson 2016; Dische et al. 
1988; Albert et al. 2007; Yumlu et al. 2009), or indirectly 
by decreasing the long-term stability of insulin formulations 
(Frokjaer and Otzen 2005; Brange and Langkjoer 1993). It 
is also a significant problem in industrial-scale production, 
where insulin aggregation leads to costly problems with col-
umn clogging during reverse-phase high-performance liquid 
chromatography purification (Gusarov et al. 2007; Majors 
2004). It is therefore important to understand the fibrillation 
of this protein, both to increase our understanding of insulin-
related amyloidosis, and to improve on existing industrial 
production procedures.
In this work, we have used biophysical methods to study 
the amyloid formation of bovine insulin, a common model 
protein in aggregation studies (Richter and Neises 2005). 
We have explored how solution pH and short-chain alcohols 
(common additives and eluents in industrial purification of 
proteins in general and pharmaceutical human insulin in par-
ticular) affect fibril formation rate and fibril morphology, as 
well as the solubility and structural stability of the native 
bovine insulin form. The study focuses on the intermediate 
pH range (pH 4.0) and thus complements and extends the 
significant body of published data that describe insulin amy-
loid formation at strongly acidic conditions (pH ≤ 2) (Waugh 
1946; Burke et al. 1972; Nielsen et al. 2001).
Materials and methods
Materials
Bovine insulin, thioflavin-T (ThT), all buffer chemicals and 
all solvents were purchased from Sigma-Aldrich. Solvents 
were of chromatography grade. Bovine insulin was pur-
chased in powdered form (Product No I5500). Thioflavin-T 
(ThT) was first dissolved in tetrahydrofuran and re-crystal-
lized to remove impurities and then dissolved in distilled 
water from a milli-Q water system (Merck Millipore, Darm-
stadt, Germany). The solution was filtered through a 0.2 µm 
syringe filter to remove undissolved particulates. The ThT 
concentration was determined by absorption on a Cary 50 
absorption spectrophotometer (Agilent Technologies, Santa 
Clara, California, US), using an extinction coefficient of 
36,000 M−1 cm−1 at 412 nm. Insulin stock solutions were 
prepared by dissolving powdered bovine insulin in a small 
amount of 100 mM HCl to ~ 15 mg/mL, followed by dilution 
into one of the following buffers: 100 mM glycine–HCl, pH 
2.2; citrate–phosphate buffer prepared from 100 mM citrate 
and 200 mM  Na2HPO4 (McIlvaine 1921), spanning from 
pH 3.0 to 7.0, or 200 mM ammonium acetate, pH 4.0. The 
insulin concentration was determined by absorption, using 
an extinction coefficient of ε280 = 5,800 M−1 cm−1.
Aggregation kinetics experiments
Aggregation kinetics was monitored by ThT fluorescence 
in a Fluostar Omega or Fluostar Optima fluorescence plate 
reader (BMG Labtech, Ortenberg, Germany) at 60 °C with-
out shaking. Samples were deposited in 100 μl triplicate in 
black half-area 96-well microtiter plates with transparent 
bottoms (Corning #3881), and the plates were sealed with 
plastic film (Bio-Rad Laboratories, Hercules, CA, U.S.) 
to avoid sample evaporation. ThT fluorescence emission 
was detected using bottom optics, a 440 ± 10 nm band pass 
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excitation filter, and a 485 ± 12 nm band pass emission filter. 
The ThT concentration was 7.2 μM in all experiments.
Solubility and fibril formation yields of insulin
The solubility of insulin as function of pH was estimated 
by preparing insulin solutions with varying pH at a con-
centration of 1 mg/ml. The solutions were centrifuged at 
13,400 rpm in an Eppendorf Minispin tabletop centrifuge 
(Eppendorf, Hamburg, Germany) for 15 min to pellet non-
dissolved insulin. The solubility was estimated by measuring 
the insulin concentration in the supernatant by absorption 
(see above). The same strategy was used to determine fibril 
formation yields at different pH values, using pre-formed 
fibrils as starting material.
Circular dichroism spectroscopy
Circular dichroism (CD) spectroscopy was used to deter-
mine the secondary structure of insulin in the presence 
of ethanol. CD spectra were recorded in 1 nm increments 
between 190 and 250 nm on a Chirascan spectropolarimeter 
(Applied Photophysics Ltd, Leatherhead, UK) using quartz 
cuvettes with 1 mm path length (Hellma GmbH, Mullheim, 
Germany). The bandwidth was 1 nm, and the integration 
time was 500 ms. The spectra were corrected for background 
contributions by subtracting the appropriate buffer blanks.
AFM and fluorescence imaging
For atomic force microscopy, fibrillar insulin was depos-
ited on freshly cleaved mica and left to settle for 5 min, 
after which the mica plates were rinsed with milli-Q water 
and dried under a gentle stream of nitrogen. AFM images 
were recorded on an NTEGRA Prima setup (NT-MDT, 
Moscow, Russian Federation) equipped with a gold-coated 
single crystal silicon cantilever (NSG-01, spring con-
stant ~ 5.1 N/m, resonance frequency of ~ 150 kHz). The 
images were processed in the Gwyddion software pack-
age (Nečas and Klapetek 2012) using planar subtraction, 
polynomial background subtraction and correction for 
linear aberrations. For fluorescence microscopy, 150 µl 
of insulin solution was placed on positively charged glass 
(Thermo Scientific, Waltham, MA, USA) and sealed with 
a 18 × 18 mm coverslip. A Zeiss AxioObserver.Z1 inverted 
fluorescence microscope (Carl Zeiss AG, Oberkochen, Ger-
many) with a 100 × oil immersion objective (NA = 1.46) was 
used in combination with a Photometrics Evolve EMCCD 
camera (Photometrics, Tuscon, AZ, USA), 100 ms exposure 
time, to obtain the images of the samples.
Results and discussion
Kinetic assay for insulin amyloid formation, 
reproducibility and monomer concentration 
dependence at pH 2.2 and pH 7.0
We set up thioflavin-T kinetic assays to monitor the aggre-
gation of bovine insulin in microtitre plates at 60 °C and 
under quiescent conditions, initially at pH 2.2 to establish 
a reproducible method, then extending to pH 7.0 to reflect 
native conditions. The resulting kinetic curves (presented 
as normalized ThT fluorescence) are presented in Fig. 1a, 
b; each condition was analysed in triplicate and all curves 
are shown. The aggregation rate of bovine insulin increases 
with increase in monomer concentration at pH 2.2 (Fig. 1a), 
which is intuitively expected and also consistent with many 
Fig. 1  Kinetics of insulin amyloid formation at pH 2.2 and pH 7.0. 
(A–B) Normalized thioflavin-T (ThT) fluorescence as function of 
time for insulin solutions with increasing concentration recorded at 
a pH 2.2 and b pH 7.0. All experiments were performed in tripli-
cate. c Half-time of amyloid formation plotted as function of mono-
mer concentration on a log–log scale. The solid lines indicate linear 
fits to data with scaling component (slope) of γ =  − 1.02 for pH 2.2 
data and γ =  + 0.75 for pH 7.0 data. d Percentage of dissolved insulin 
measured following sedimentation of the insoluble fraction on freshly 
prepared samples with a total insulin concentration of 172 μM. The 
insulin was pre-dissolved in 100 mM HCl prior to dilution to the indi-
cated pH as described in Materials and Methods
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previous studies (see for example Brange and Langkjoer 
1993; Nielsen et al. 2001). Figure 1c shows the reaction 
half-times, i.e. the time at which 50% of the maximum ThT 
fluorescence has been reached, as function of the initial insu-
lin concentration on a log–log scale. The scaling component, 
i.e. the slope of the fitted straight line to the half-time data, 
for insulin aggregation kinetics at pH 2.2 is  − 1.02, which is 
consistent with a nucleation-dependent aggregation mecha-
nism (Meisl et al. 2016). At pH 7.0 (Fig. 1b), insulin amy-
loid formation instead displays an inverse dependence on 
monomer concentration; the aggregation rate decreases with 
increase in protein concentration, which is further illustrated 
by the positive slope (γ =   +   0.75) in the corresponding half-
time plot in Fig. 1c. This is, from an amyloid formation point 
of view, an anomalous behaviour that can be explained by 
that insulin, in addition to existing as a monomer, populates 
higher-order oligomeric states that are resilient to amyloid 
formation; or interfere with fibril elongation (Ziaunys et al. 
2018). These higher-order states can be significant, or even 
predominant, at pH 7.0 despite that no stabilizing zinc was 
added (Ziaunys et al. 2018; Waugh et al. 1953; Goldman and 
Carpenter, 1974).
The fibril yields for the reactions shown in Fig. 1 were 
estimated by centrifugation experiments to sediment amy-
loid fibrils formed at  a starting concentration of 58 μM insu-
lin. The yield was to 91 ± 8% at pH 2.2 and 90 ± 5% (n = 3) 
at pH 7.0, suggesting that as monomeric insulin is incorpo-
rated into fibrils, the equilibrium between monomers and 
higher-order folded oligomers at pH 7.0 is shifted, such that, 
e.g. hexamers eventually dissociate, and the resulting mono-
mers thereafter are incorporated into the growing fibrils. The 
inverse concentration dependence suggests that it is this con-
version that is rate limiting in the amyloid forming reaction 
at pH 7.0. We also used centrifugation to sediment insolu-
ble insulin in 1 mg/ml solutions to investigate the solubility 
across a range of buffers with different pH values (Fig. 1d). 
We show that insulin solubility is high across most of the 
assayed pH range, with the exception of pH 5.0–6.0, which is 
close to to insulin’s isolectric point (pI = 5.3 (Wintersteiner 
and Abramson 1933)).
The fibril formation rate of insulin is the lowest close 
to the isoelectric point
Next, we monitored the amyloid fibril formation kinetics 
of bovine insulin at one fixed concentration (64 μM) across 
a range of different buffer pH values (3.0–7.0). Figure 2a 
shows ThT fluorescence as function of time. The kinetics of 
insulin amyloid formation is clearly fastest at pH 3.0 or at pH 
7.0 and occurs considerably slower (~ 50% as measured by 
half-time of fibril formation) at pH 4.0. At intermediate pH 
(5.0–6.0), close to insulin’s isoelectric point, amyloid forma-
tion is strongly inhibited, thereby hindering measurement 
of reliable half-times within the assayed time range. The 
aggregation rate is not only slowed down, but the reactions 
also become more stochastic in the intermediate pH range. 
This is particularly apparent at pH 5.0, which is very near 
insulin’s isoelectric point; charge neutralization appears in 
this case to impede rather than to accelerate self-assembly. 
In this respect, insulin behaves differently from for example 
the Alzheimer’s disease-related amyloid-β peptide or the 
Parkinson protein α-synuclein where the reduced electro-
static repulsion close to their respective pI act to catalyse 
their fibrillation (Guo et al. 2005). Furthermore, the slow 
aggregation as well as apparently stochastic kinetics that 
insulin displays at pH 5.0–6.0 coincides with low solubility 
of the protein (Fig. 1d) and supports that near insulin’s pI, 
amyloid formation occurs in competition with precipitation.
By comparing the aggregation reaction rates in Fig. 2a 
with measurements of insulin solubility (Fig. 1d), we note 
that at pH 4.0, insulin amyloid formation is retarded, but 
the solubility remains high. From a protein purification per-
spective, this is clearly an advantageous situation; conspicu-
ously, these also appear to be commonly used conditions in 
Fig. 2  Insulin fibrillation at different pH values. a Kinetics of insulin 
amyloid formation monitored by ThT fluorescence in citrate–phos-
phate buffers with indicated pH. The initial insulin monomer concen-
tration was 64 μM. b Normalized ThT emission from (a), including 
64 µM insulin aggregated in ammonium acetate buffer with indicated 
pH. All experiments were performed in triplicate, all replicates are 
shown in the plot
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pharmaceutical production of the human insulin form. In 
industrial settings, ammonium acetate buffer is often used 
for purification at pH 4.0. We therefore compared the aggre-
gation rate in citrate–phosphate and ammonium phosphate 
(Fig. 2b), showing a somewhat slower rate in the latter (half-
time of 7.7 ± 0.8 h compared to 6.5 ± 0.1 h in citrate phos-
phate). We foremost attribute this to the differences in ionic 
strength of the two buffer systems, as salt concentration has 
been demonstrated to be important for insulin’s aggregation 
rate (Nielsen et al. 2001). We also examined the concentra-
tion dependence of insulin fibrillation in ammonium acetate, 
pH 4.0 (Fig. 3). It is clear both from the aggregation curves 
(Fig. 3a) and half-times (Fig. 3b) that at this intermediate 
pH, insulin does not have a clear concentration-dependent 
aggregation behaviour. It thus behaves differently, and in 
some sense intermediate, from what is seen at pH 2.2 and 
pH 7.0. 
Next, we examined the morphological appearance of insu-
lin fibrils formed at pH 2.2, pH 4.0 and pH 7.0 using both 
atomic force microscopy (AFM), and fluorescence imaging 
with ThT as counterstain (Fig. 4). The images confirm that 
the ThT fluorescence that we observe in the kinetic experi-
ments is consistent with the formation of amyloid fibrils in 
all cases, also at pH 4.0, which is reasonably close to the 
isoelectric point and thus conditions where native insulin 
becomes insoluble. The morphology of the ensuing insulin 
fibrils differs, however, distinctly with pH. At pH 2.2, aggre-
gated insulin deposits on mica as individual fibrils and at a 
high concentration; they were also always evenly dispersed 
over the entire mica substrate. This agrees very well with the 
corresponding fluorescence images (which were acquired on 
fibrils adsorbed on a glass substrate in aqueous solution). 
At pH 4.0 and 7.0, the fibrils behave differently. First, they 
were considerably more difficult to locate and image on the 
mica substrate, despite that we found the fibril yields at the 
different pH values to be high in all cases (for pH 4.0, the 
fibril yield was > 99.5%). At pH 4.0 and pH 7.0, the insulin 
amyloid fibrils tend to form dense clusters in addition to dis-
persed fibrils. This is supported by the fluorescence images 
that show very bright macroscopic aggregates in the field of 
view. These structures were in fact so brightly fluorescent 
compared to the fibrils imaged at pH 2.2 that we had to 
bleach the fluorescence before recording the actual images 
to avoid oversaturating the detector.
To mimic conditions relevant to industrial purification 
of insulin, we investigated the effect of three short-chain 
alcohols (methanol, ethanol and isopropanol) on insulin 
aggregation in ammonium acetate buffer. We monitored 
ThT kinetics as function of increasing concentration (range: 
0–50% v/v) of each alcohol (Fig. 5a–c). All three alcohols 
initially retarded fibril formation in a concentration-depend-
ent manner up to a certain volume fraction, whereafter the 
rate was again observed to increase, suggesting that the sol-
vent concentration in eluting buffers can be optimized to 
obtain maximum elution and, simultaneously, reduce the 
risk of aggregation. This behaviour is also depicted by the 
change in half-time as function of alcohol concentration 
shown in Fig. 5a. Ethanol and isopropanol can retard fibril 
formation at pH 4.0 by as much as three to four times at the 
most effective alcohol:buffer mixing ratio, which according 
to our result is around 30–35%. Methanol is apparently a 
weaker modulator (it retards fibril formation by  ~ 2 times); 
higher concentrations (40%) are also needed to reach maxi-
mal effect. The finding that methanol is less efficient than 
ethanol and isopropanol suggests that fibril formation of 
bovine insulin is significantly dependent on solvent polarity, 
with mixing in of increasingly non-polar additives having a 
retarding (aggregation-protective) effect.
We also report the change in the end-point ThT fluores-
cence as function of alcohol concentration; these data were 
extracted from the non-normalized raw data corresponding 
to the kinetic curves shown in Fig. 5. The end-point values 
(Fig. 6b) decrease steadily and significantly with increas-
ing alcohol concentration, but do not correlate with the 
Fig. 3  (a) Kinetics of insulin 
amyloid formation monitored by 
ThT fluorescence in ammonium 
acetate, pH 4.0, at different 
insulin concentrations. b Reac-
tion half-times extracted from 
the kinetic traces in (a) as func-
tion of insulin concentration. 
Error bars represent standard 
deviation (n = 3)
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half-times in Fig. 6a. This is probably due to ThT’s fluo-
rescence being sensitive both to ThT binding affinity and to 
the quantum yield of each bound dye molecule (Lindberg 
et al.2015, 2017). To further investigate the effect of ethanol 
on insulin during fibrillation, we used AFM to image sam-
ples from the end point of the fibrillation reaction. As seen 
in Fig. 7a, insulin readily forms classic amyloid fibrils in 
ammonium acetate, pH 4.0, whereas the sample aggregated 
in the presence of 30% EtOH (Fig. 7b) contains, at high 
abundance, oligomeric particles,  ~ 2–3 nm in size, which 
could be consistent with dimers to hexamers (reported 
as 20 × 40 Å, and 35 × 50 Å, respectively (Blundell et al. 
1972)). Our data thus suggest that ethanol as co-solvent 
Fig. 4  Insulin fibrils aggregated at pH 2.2 (left), pH 4 (middle) and pH 7 (right), imaged by atomic force microscopy (a–c) or ThT fluorescence 
microscopy (d–f). The scale bar is 2 µm in the AFM images, and 10 µm in the fluorescence images
Fig. 5  Effect of alcohols on insulin fibrillation kinetics at pH 4.0. 
Amyloid formation kinetics monitored by ThT fluorescence in ammo-
nium acetate buffer with increasing concentrations of a methanol b 
ethanol, and c isopropanol. All kinetic data were recorded in tripli-
cate and all traces are shown in the figures. The percentage of solvent 
refers to volume fraction
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drives insulin into oligomeric assemblies, which are likely 
off-pathway due to the reduction in aggregation rate.
Lastly, to further explore why alcohols modulate the 
amyloid formation kinetics of bovine insulin, we used CD 
spectroscopy to examine the secondary structure of non-
aggregated insulin at pH 4.0 in solutions with increasing 
concentrations of ethanol. The resulting CD spectra in 
Fig. 8 show that ethanol up to a concentration of 40% acts 
to enhance the negative ellipticity in the 208 nm absorp-
tion band relative to the 222 nm absorption band. This can 
be attributed to the relative packing of α-helices in the pro-
tein native state; specifically, a decrease in the 222/208 nm 
ratio is indicative of unpacking of coiled helices (Lau et al. 
1984; McNamara et al. 2008). Similar behaviour has been 
reported previously in relation to destabilization of the 
insulin dimer by ethanol at low pH and could thus explain 
Fig. 6  a Reaction half-times extracted from the data in Fig. 4 for the 
kinetics of insulin amyloid formation in ammonium acetate buffer 
containing increasing volume fractions of respectively methanol 
(red, MeOH), ethanol (blue, EtOH), and isopropanol (green, PrOH). 
b Change in end-point ThT fluorescence for the kinetic traces shown 
in Fig. 4 reported as function of alcohol concentration for methanol 
(red), ethanol (blue), and isopropanol (green). The error bars repre-
sent standard deviation (n = 3)
Fig. 7  (a–b) Atomic force 
microscopy imaging of insulin 
aggregated in ammonium 
acetate, pH 4.0, in the absence 
(a) and presence (b) of 30% 
(vol/vol) EtOH. The scale bar 
is 2 µm
Fig. 8  Far-UV CD spectra showing conformational change of insulin 
induced by ethanol co-solvation at pH 4.0
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the increase in amyloid fibril formation rate ≥ 30% ethanol 
(vol/vol) (Brems et al. 1990; Dzwolak et al. 2005).
Conclusions
We have studied the amyloid formation kinetics of insulin as 
a function of protein concentration and pH and in the pres-
ence of increasing concentrations of short-chain alcohols at 
pH 4.0, a pH that we identified as particularly interesting 
due to its common use in reverse-phase HPLC purification 
of pharmaceutical human insulin and because of our findings 
that it presents the best combination of high solubility and 
slow aggregation rate. This is advantageous and important 
from the perspective of avoiding adverse aggregation in the 
industrial manufacturing process. Further, by examining 
the concentration dependence on insulin aggregation at pH 
2.2, we confirm previous observations suggesting that the 
aggregation mechanism is dependent not only on primary 
nucleation, but strongly and decisively on secondary and 
auto-catalytic processes. At pH 7.0 we find that the aggre-
gation behaviour is modulated by the ability of the insulin 
monomer to associate into natively folded oligomers, pre-
sumably hexamers. Therefore, conditions that monomerize 
insulin at physiological pH also render the protein more sus-
ceptible to aggregation. Finally, we demonstrate that at pH 
4.0, folded insulin can be stabilized by alcohols, resulting 
in significant retardation of aggregation rates, presumably 
due to the formation of off-pathway oligomers. We find that 
ethanol and isopropanol are better stabilizers than methanol, 
and that these two alcohols increase the reaction half-times 
nearly linearly up to a concentration of 35–40% (volume 
fraction). Altogether, our study provides details of insulin 
fibrillation kinetics in different solution conditions relevant 
to pharmaceutical production. It shows that pH 4.0 provides 
optimal, aggregation-limited conditions which are well 
suited for purification, and suggests that further stabilization 
of the native insulin can be obtained by common solvents 
used as eluents by the pharmaceutical industry.
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